Acute zonal occult outer retinopathy
Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare, presumed inflammatory retinopathy that involves the outer regions of the retina and is typically associated with visual field defects and visual disturbances known as photopsia.
-
First characterized in 1992 by Gass.
source quote
first characterized in 1992 by Gass
-
Categorized into a group of disorders called white dot syndromes.
source quote
categorized into a group of disorders called white dot syndromes
-
Most commonly seen in young to middle-age adults with a female predominance of approximately 3:1.
source quote
most commonly seen in young to middle-age adults with a female predominance of approximately 3:1
-
Etiology is likely multifactorial, possibly autoimmune or viral.
source quote
etiology is more likely to be multifactorial than autoimmune alone
-
Affects the retina at the level of the retinal pigment epithelium (RPE) and photoreceptors.
source quote
condition appears to affect the retina at the level of the retinal pigment epithelium (RPE) and photoreceptors
-
Patients typically present with photopsia described as shining or shimmering lights.
source quote
photopsia is typically described as “shining” or “shimmering” lights
-
Visual field loss may present as enlargement of the physiologic blind spot or peripheral vision loss.
source quote
visual field loss may present as enlargement of the physiologic blind spot or other field defects such as peripheral vision loss
-
Blurry vision may occur less commonly.
source quote
blurry vision
-
Night blindness is a possible symptom.
source quote
night blindness as a possible symptom
-
Most patients have unilateral involvement at presentation, but many develop bilateral involvement.
source quote
majority of patients have unilateral involvement at the time of presentation, however many will develop bilateral involvement as the condition progresses
-
Initial examination typically shows mildly decreased visual acuity of 20/40 or better with a normal slit lamp examination.
source quote
mildly decreased visual acuity of 20/40 or better on the Snellen chart with a normal slit lamp examination
-
Mild vitritis may be indicated by a small number of cells within the vitreous.
source quote
mild vitritis indicated by a small number of cells within the vitreous
-
Patients may have a relative afferent pupillary defect (RAPD).
source quote
relative afferent pupillary defect (RAPD)
-
AZOOR is a diagnosis of exclusion.
source quote
AZOOR remains a diagnosis of exclusion, meaning that other similar conditions must be ruled out first
-
Diagnostic workup may include OCT, visual field testing, fundus photography, fluorescein angiography, fundus autofluorescence, and ERG.
source quote
diagnostic workup may include optical coherence tomography (OCT) , visual field testing , fundus photography , fluorescein angiography , fundus autofluorescence, and ERG
-
Fundoscopy is often normal initially, but RPE mottling and retinal atrophy may be seen as the condition progresses.
source quote
RPE mottling and retinal atrophy may be seen as the condition progresses
-
Nearly all patients will have abnormalities on ERG, varying between rod-dysfunction, cone-dysfunction or both.
source quote
Nearly all patients will have abnormalities on ERG, but the abnormalities may vary between rod-dysfunction, cone-dysfunction or both
-
Differential diagnosis includes other white dot syndromes, inherited retinal degenerations, autoimmune retinopathy, infectious retinopathy, and toxic retinopathy.
source quote
differential diagnosis for patients with suspected AZOOR includes other white dot syndromes such as multiple evanescent white dot syndrome (MEWDS) or Birdshot chorioretinopathy , inherited retinal degenerations such as retinitis pigmentosa , autoimmune retinopathy, acute idiopathic enlarged blindspot syndrome (AIEBS), infectious retinopathy such as syphilis or HIV , toxic retinopathy, and others
-
Therapies include local and systemic steroids, NSAIDs, antimicrobials, and watchful observation.
source quote
Many different therapies have been utilized in the management of AZOOR including local and systemic steroids, NSAIDs , antimicrobials, and watchful observation
-
No randomized control trials have evaluated treatments for AZOOR.
source quote
there have been no randomized control trials evaluating treatments for AZOOR
-
Choroidal neovascular membranes may rarely occur as a late manifestation.
source quote
Rarely, patients with AZOOR have been reported to have choroidal neovascular membranes as a late manifestation of the disease
-
Over time, retinal arteries may thin and the optic disk may become pale.
source quote
the retinal arteries may thin and the optic disk may become pale
The natural history of the disease appears to show stabilization or improvement within 6 months in a majority of cases, even without treatment.
| Acute zonal occult outer retinopathy | |
|---|---|
| Other names | AZOOR |
| Pronunciation |
|
| Specialty | Ophthalmology |
Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare, presumed inflammatory retinopathy that involves the outer regions of the retina and is typically associated with visual field defects and visual disturbances known as photopsia.[1] It was first characterized in 1992 by Gass [2] and since then, has been categorized into a group of disorders called white dot syndromes.[3] The disease served as a major plot point in the BBC drama Second Sight which aired from 2000 to 2001.[4]
AZOOR is most commonly seen in young to middle-age adults with a female predominance of approximately 3:1.[1][5][6] One systematic review found the median age of onset to be 35 years; however, the condition may present anywhere between 12 and 85 years of age.[1]
Though the exact mechanism is still undetermined, several have theorized the condition to be autoimmune or viral in origin.[5] One study involving 51 patients with AZOOR found that 20% had a viral-like illness preceding presentation while 28% of patients had a history of at least one autoimmune disease.[7] One systematic review found that of 427 patients with AZOOR, 27% had an extraocular autoimmune disease at the time of presentation.[1]
Some investigations have revealed the presence of anti-retinal autoantibodies in patients with AZOOR, further suggesting an autoimmune etiology.[8] However, anti-retinal autoantibodies can be seen in a variety of other conditions without direct effects, and some patients with AZOOR do not have autoantibodies present.[1][5] Furthermore, given that patients have varying responses to steroids and immunomodulatory treatment, the etiology is more likely to be multifactorial than autoimmune alone.[1] There has been no evidence that genetics plays a role in the condition.[6] Though the exact anatomic target has not been verified, the condition appears to affect the retina at the level of the retinal pigment epithelium (RPE) and photoreceptors, given the findings on electroretinography (ERG).[5]
Patients with AZOOR typically present with one or more visual complaints including, most commonly, photopsia, as well as visual field loss or less commonly, blurry vision.[1] Other case series have reported night blindness as a possible symptom as well.[8] A majority of patients have unilateral involvement at the time of presentation, however many will develop bilateral involvement as the condition progresses.[5] The photopsia is typically described as “shining” or “shimmering” lights.[1] The visual field loss may present as enlargement of the physiologic blind spot or other field defects such as peripheral vision loss.[1][5][8]
Upon initial examination and testing, patients will typically have mildly decreased visual acuity of 20/40 or better on the Snellen chart with a normal slit lamp examination, though there may be a mild vitritis indicated by a small number of cells within the vitreous.[1][5] Patients may have a relative afferent pupillary defect (RAPD).[9] Fundoscopy, or visualization of the back of the patient's eye including the retina and optic nerve, is often normal in AZOOR. However, RPE mottling and retinal atrophy may be seen as the condition progresses.[1][10] Also with time, the retinal arteries may thin and the optic disk may become pale.[6][8][9]
Rarely, patients with AZOOR have been reported to have choroidal neovascular membranes as a late manifestation of the disease.[6]
Nearly all patients will have abnormalities on ERG, but the abnormalities may vary between rod-dysfunction, cone-dysfunction or both. The abnormalities typically coincide with the visual field defects.[1]
AZOOR remains a diagnosis of exclusion, meaning that other similar conditions must be ruled out first.[6] A diagnostic workup may include optical coherence tomography (OCT), visual field testing, fundus photography, fluorescein angiography, fundus autofluorescence, and ERG.[1][3]
The differential diagnosis for patients with suspected AZOOR includes other white dot syndromes such as multiple evanescent white dot syndrome (MEWDS) or Birdshot chorioretinopathy, inherited retinal degenerations such as retinitis pigmentosa, autoimmune retinopathy, acute idiopathic enlarged blindspot syndrome (AIEBS), infectious retinopathy such as syphilis or HIV, toxic retinopathy, and others.[5]
Many different therapies have been utilized in the management of AZOOR including local and systemic steroids, NSAIDs, antimicrobials, and watchful observation, none of which have proven to be more effective than the other.[1][10] Unfortunately, due in part to the rarity of this condition, there have been no randomized control trials evaluating treatments for AZOOR, so the data on treatment efficacy comes from case series and cohort studies.[1]
Fortunately, the natural history of the disease appears to show stabilization or improvement within 6 months in a majority of cases, even without treatment.[1]
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Lin BR, Russell JF, Al-Khersan H, Goldhardt R (December 1, 2022). "A Systematic Review of Acute Zonal Occult Outer Retinopathy with a Focus on Attempted Treatment Modalities". Current Ophthalmology Reports. 10 (4): 168–178. doi:10.1007/s40135-022-00305-4. ISSN 2167-4868. PMC 9894323.
- ↑ Gass JD (June 1993). "Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992". Journal of Clinical Neuro-Ophthalmology. 13 (2): 79–97. ISSN 0272-846X. PMID 8340485.
- 1 2 Sen A, Rao C, Biswas J (September 2024). "An update of multimodal imaging in white dot syndrome". Oman Journal of Ophthalmology. 17 (3): 325–333. doi:10.4103/ojo.ojo_116_24. ISSN 0974-620X. PMC 11620295.
- ↑ "See No Evil: Detective's New Insight". New York Times. September 26, 1999.
- 1 2 3 4 5 6 7 8 "Acute Zonal Occult Outer Retinopathy (AZOOR)". EyeWiki. Retrieved March 5, 2026.
- 1 2 3 4 5 Roy R, Dutta Majumder P (July 2024). "Current understanding of acute zonal occult outer retinopathy (AZOOR)". Indian Journal of Ophthalmology. 72 (7): 935–937. doi:10.4103/IJO.IJO_3228_23. ISSN 0301-4738.
- ↑ Gass J, Agarwal A, Scott IU (September 2002). "Acute zonal occult outer retinopathy: a long-term follow-up study". American Journal of Ophthalmology. 134 (3): 329–339. doi:10.1016/S0002-9394(02)01640-9.
- 1 2 3 4 Qian CX, Wang A, DeMill DL, Jayasundera T, Branham K, Abalem MF, et al. (April 2017). "Prevalence of Antiretinal Antibodies in Acute Zonal Occult Outer Retinopathy: A Comprehensive Review of 25 Cases". American Journal of Ophthalmology. 176: 210–218. doi:10.1016/j.ajo.2016.12.001. PMC 6605038.
- 1 2 Tsang SH, Sharma T (2018). "Acute Zonal Occult Outer Retinopathy (AZOOR) and Related Diseases". In Tsang SH, Sharma T (eds.). Atlas of Inherited Retinal Diseases. Vol. 1085. Cham: Springer International Publishing. pp. 233–237. doi:10.1007/978-3-319-95046-4_49. ISBN 978-3-319-95045-7. PMID 30578522. Retrieved March 5, 2026.
- 1 2 Monson DM, Smith JR (January 2011). "Acute Zonal Occult Outer Retinopathy". Survey of Ophthalmology. 56 (1): 23–35. doi:10.1016/j.survophthal.2010.07.004.